AMA CPT® Assistant - 2024 Issue 2 (February)
Immune Globulin and Vaccine Codes: Summary for 2024 (February 2024)
February 2024 pages 1-30 Immune Globulin and Vaccine Codes: Summary for 2024 Four new vaccine product codes and two new immune globulin codes were established in the Current Procedural Terminology (CPT®) 2024 code set. This article provides an overview of these new codes. Immune Globulins, Serum or Recombinant Products 90380Respiratory syncytial virus, monoclonal antibody, seasonal dose; 0.5 mL dosage, for intramuscular use 903811 mL dosage, for intramuscular use Vaccines, Toxoids 90589Chikungunya virus vaccine, live attenuated, for intramuscular use 90679Respiratory syncytial virus vaccine, preF, recombinant, subunit, adjuvanted, for intramuscular use 90683Respiratory syncytial virus vaccine, mRNA lipid nanoparticles, for...
Subscribe or sign in to view the full article.
Article Overview
This February 2024 CPT Assistant article reviews newly established immune globulin and vaccine product codes in the CPT 2024 code set. It is aimed at coders, billing staff, and clinicians who need a high-level understanding of the new products, the related administration codes referenced by the article, and the broader clinical and public health context behind the updates.
Why This Topic Matters
It helps readers identify what changed in the CPT 2024 vaccine and immune globulin area and understand which general topics, specialties, and organizations are involved in the update.
Article Sections
-
February 2024 pages 1-30
Introductory material identifying the publication span and the scope of the CPT 2024 update coverage.
-
Immune Globulins, Serum or Recombinant Products
Overview of the new immune globulin product codes and their place in the 2024 CPT update.
-
Vaccines, Toxoids
Overview of the new vaccine product codes included in the 2024 CPT update.
-
Immune Globulin Codes
Background discussion on the new immune globulin-related CPT additions and the associated clinical context.
-
Vaccine Product Codes
Discussion of the new vaccine product codes, including the affected products and the general population groups referenced in the article.
-
Clinical Example (90380) / Description of Procedure (90380)
A clinical scenario and corresponding procedural discussion related to one of the new immune globulin product codes.
-
Clinical Example (90381) / Description of Procedure (90381)
A clinical scenario and corresponding procedural discussion related to one of the new immune globulin product codes.
-
Clinical Example (90589) / Description of Procedure (90589)
A clinical scenario and corresponding procedural discussion related to one of the new vaccine product codes.
-
Clinical Example (90679) / Description of Procedure (90679)
A clinical scenario and corresponding procedural discussion related to one of the new vaccine product codes.
-
Clinical Example (90683) / Description of Procedure (90683)
A clinical scenario and corresponding procedural discussion related to one of the new vaccine product codes.
-
Clinical Example (90623) / Description of Procedure (90623)
A clinical scenario and corresponding procedural discussion related to one of the new vaccine product codes.
-
References
Source references and external public health or regulatory resources cited by the article.
What You Will Learn
- What types of CPT 2024 immune globulin and vaccine product updates are covered
- Which general clinical areas and patient groups are discussed in relation to the new products
- What related administration code families are referenced in the article
- What external organizations and public health sources are cited in support of the update
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Physicians and qualified health care professionals
- Compliance and coding educators
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com